Whittier Trust Co. Purchases 21,242 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Whittier Trust Co. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 63,791 shares of the medical equipment provider’s stock after buying an additional 21,242 shares during the quarter. Whittier Trust Co.’s holdings in Intuitive Surgical were worth $33,295,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $492.06 on Thursday. The stock has a market cap of $175.26 billion, a price-to-earnings ratio of 76.76, a PEG ratio of 5.85 and a beta of 1.43. The business has a 50 day simple moving average of $564.39 and a 200 day simple moving average of $531.62. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last quarter. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ISRG shares. Barclays upped their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.